PO-1571: Radiomics for prediction of metastatic melanoma patient survival after immunotherapy. (November 2020) - Gabrys, H.; Basler, L.; Hogan, S.; Pavic, M.; Bogowicz, M.; Vuong, D.; Tanadini-Lang, S.; Förster, R.; Huellner, M.; Dummer, R.; Guckenberger, M.; Levesque, M.P.